MAB injections are a useful part of the arsenal, but not a new class of drug, and are only a good choice for a subset of sufferers. I am very frustrated that t

MAB injections are a useful part of the arsenal, but not a new class of drug, and are only a good choice for a subset of sufferers. I am very frustrated that the research on calcilytics, which look so promising, appear hopelessly and inexplicably stalled. People in academia won't even answer my emails asking why clinical trials aren't proceeding.